Chongqing Zhifei Bio Products - Asset Resilience Ratio

Latest as of September 2023: -0.08%

Chongqing Zhifei Bio Products (300122) has an Asset Resilience Ratio of -0.08% as of September 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥-41.38 Million

≈ $-6.05 Million USD Cash + Short-term Investments

Total Assets

CN¥49.27 Billion

≈ $7.21 Billion USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2014–2024)

This chart shows how Chongqing Zhifei Bio Products's Asset Resilience Ratio has changed over time. Check 300122 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Chongqing Zhifei Bio Products's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Chongqing Zhifei Bio Products (300122) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	CN¥0.00	0%
Short-term Investments	CN¥-41.38 Million	-0.08%
Total Liquid Assets	CN¥-41.38 Million	-0.08%

Asset Resilience Insights

Limited Liquidity: Chongqing Zhifei Bio Products maintains only -0.08% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company primarily holds liquidity in cash and equivalents rather than short-term investments.

Chongqing Zhifei Bio Products Industry Peers by Asset Resilience Ratio

Compare Chongqing Zhifei Bio Products's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Halozyme Therapeutics Inc NASDAQ:HALO	Biotechnology	12.71%
Soleno Therapeutics Inc NASDAQ:SLNO	Biotechnology	20.15%
Neuren Pharmaceuticals Ltd AU:NEU	Biotechnology	90.43%
Genfit S.A. PA:GNFT	Biotechnology	64.01%
Hyundai Bioscience Co. Ltd KQ:048410	Biotechnology	22.98%
Altimmune Inc NASDAQ:ALT	Biotechnology	82.06%
Clarity Pharmaceuticals Ltd AU:CU6	Biotechnology	73.99%
Jiangsu GDK Biotechnology Co Ltd SHG:688670	Biotechnology	9.82%

Annual Asset Resilience Ratio for Chongqing Zhifei Bio Products (2014–2024)

The table below shows the annual Asset Resilience Ratio data for Chongqing Zhifei Bio Products.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2024-12-31	0.02%	CN¥11.53 Million ≈ $1.69 Million	CN¥49.91 Billion ≈ $7.30 Billion	+0.05pp
2022-12-31	-0.03%	CN¥-10.15 Million ≈ $-1.49 Million	CN¥38.00 Billion ≈ $5.56 Billion	+0.14pp
2021-12-31	-0.17%	CN¥-51.45 Million ≈ $-7.53 Million	CN¥30.05 Billion ≈ $4.40 Billion	+0.15pp
2020-12-31	-0.32%	CN¥-49.19 Million ≈ $-7.20 Million	CN¥15.22 Billion ≈ $2.23 Billion	-0.76pp
2019-12-31	0.44%	CN¥48.09 Million ≈ $7.04 Million	CN¥10.94 Billion ≈ $1.60 Billion	+0.92pp
2018-12-31	-0.49%	CN¥-33.04 Million ≈ $-4.84 Million	CN¥6.81 Billion ≈ $996.54 Million	-0.38pp
2017-12-31	-0.11%	CN¥-4.41 Million ≈ $-644.69K	CN¥4.11 Billion ≈ $600.82 Million	+0.14pp
2016-12-31	-0.25%	CN¥-6.76 Million ≈ $-989.50K	CN¥2.71 Billion ≈ $396.48 Million	-0.28pp
2015-12-31	0.03%	CN¥782.09K ≈ $114.44K	CN¥2.68 Billion ≈ $392.41 Million	+0.39pp
2014-12-31	-0.36%	CN¥-9.72 Million ≈ $-1.42 Million	CN¥2.71 Billion ≈ $397.21 Million	--

pp = percentage points

About Chongqing Zhifei Bio Products

SHE:300122 China Biotechnology

Market Cap

$4.52 Billion

CN¥30.88 Billion CNY

Market Cap Rank

#3783 Global

#534 in China

Share Price

CN¥12.90

Change (1 day)

+1.10%

52-Week Range

CN¥11.37 - CN¥25.06

All Time High

CN¥11976.62